Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedDeleted detailed outcome measures and safety event tables from the Study Results page, including all-Cause TEAEs, SAEs by SOC/PT, and related safety summaries.SummaryDifference12%

- Check34 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3, indicating a minor site version update.SummaryDifference0.0%

- Check50 days agoChange DetectedVersion updated from v3.4.2 to v3.4.3; a minor update/patch.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded expanded Study Results data with new safety and laboratory outcome tables, including TEAEs/SAEs by SOC and PT, vital signs, and laboratory abnormalities across dose groups; introduced 'Number Analyzed' and 'Overall Number of Participants Analyzed' details.SummaryDifference24%

- Check71 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous v3.4.1. This metadata change does not alter any study results or core content.SummaryDifference0.0%

Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.